Official Title
Evaluation of a Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service Pre-, Intra- and Post-COVID-19 Pandemic: a Retrospective Cohort Study
Brief Summary

Choledocholithiasis is reported to be present in 15-20% of patients with symptomaticgallstones. The single-stage management consists of performing either laparoscopic commonbile duct exploration (LCBDE) or intraoperative endoscopic retrogradecholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC).Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly beenimpacted. The pandemic has had ramifications on patient and staff safety, surgicaltechniques, minimally invasive procedures, theatre workflow, education and training.We analysed a series of LCBDE procedures in our institution pre-, intra- andpost-COVID-19 pandemic to assess the feasibility, efficacy and safety of thissingle-stage treatment approach following the pandemic.

Detailed Description

Not Provided

Completed
Gallstone

Other: Single-stage LC + LCBDE

Choledochotomy and transductal common bile duct exploration or transcystic
choledochoscopy and common bile duct exploration

Eligibility Criteria

Inclusion Criteria:

- Patients that underwent single-stage LC + LCBDE for the management of
choledocholithiasis with concomitant gallstones.

Exclusion Criteria:

- Patients that underwent LC only or LCBDE only

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Locations

Not Provided

Not Provided

Imperial College London
NCT Number
MeSH Terms
COVID-19
Gallstones